US Patent 11932879 Mumps virus as a potential oncolytic agent

Patent 11932879 was granted and assigned to Mayo Foundation for Medical Education and Research (MFMER) on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Mayo Foundation for Medical Education and Research (MFMER)

Current Assignee

Mayo Foundation for Medical Education and Research (MFMER)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119328790

Patent Inventor Names

Arun Ammayappan0

Stephen James Russell0

Mark J. Federspiel0

Gennett Pike0

Date of Patent

March 19, 2024

Patent Application Number

178476290

Date Filed

June 23, 2022

Patent Citations

‌

US Patent 10577591 Mumps virus as a potential oncolytic agent

‌

US Patent 7361496 Rescue of mumps virus from cDNA

‌

US Patent 7759104 Paramyxoviridae virus preparations

‌

US Patent 7781413 SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

‌

US Patent 11401511 Mumps virus as a potential oncolytic agent

Patent Primary Examiner

‌

Agnieszka Boesen

Patent abstract

This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.